SanBio Company Limited provided consolidated earnings guidance for the first half of fiscal year ending January 31, 2022. For the period, the company expects operating loss were JPY 3,052 million as compared to JPY 3,492 million a year ago. Net loss attributable to owners of parent were JPY 2,134 million as compared to JPY 3,551 million a year ago. Net loss per share were JPY 41.21 as compared to JPY 68.57 a year ago.